Philips, a global leader in health technology and IVUS solutions, announced that a worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions
October 20, 2021
First-ever Global Consensus for the Appropriate Use of IVUS in Peripheral Vascular Disease Interventions
October 20, 2021 — Philips, a global leader in health technology and intravascular ultrasound (IVUS) solutions,…
Read More
The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, for the treatment of long tibial occlusive lesions (TASC C & D) in patients with Critical Limb Ischemia (CLI). It was presented at VIVA 2021.
October 20, 2021
18-Month Below-the-Knee Data With MedAlliance’s SELUTION SLR Presented at VIVA
October 20, 2021 — 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a late-…
Read More
the Eluvia stent exhibited superiority with a primary patency rate of 85.4% versus 76.3% with BMS (p=0.0077).1 The analysis also confirmed a significantly greater rate of sustained clinical improvement without reintervention
October 20, 2021
Boston Scientific Eluvia Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents
October 20, 2021 — Boston Scientific Corporation announced positive data for the Eluvia Drug-Eluting Vascular Stent…
Read More
The CorWave LVAD uses a pulse pump rather than a rotary pump to move blood, so it more closely simulates the movement of blood in a read heart.
October 20, 2021
Innovative New Pulsatile LVAD Wins 2021 HealthTech Award
October 20, 2021 – CorWave, a French medtech company developing a next-generation heart pump, won the 2021 HealthTech…
Read More
The Biotricity Biocare Cardiac app for the Samsung Galaxy Watch4 offers mobile cardiac telemetry with real-time monitoring and transmission of ECG information. It also can interface with FDA-cleared devices, including a digital thermometer, a pulse oximeter and a blood pressure cuff.
October 15, 2021
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
October 15, 2021 — Biotricity Inc. announced the release of Biocare Cardiac, a personal, cardiac health application for…
Read More
7 areas to consider to improve STEMI heart attack care
October 15, 2021
American Heart Association Offers Approaches to Improve STEMI Heart Attack Care 
October 15, 2021 — The American Heart Association (AHA) released a new policy statement that offers policy…
Read More
he correlation between poor oral health and COVID-19 severity, as well as the correlation between oral health and delayed recovery, demonstrates a potential need to consider oral health an additional risk factor for cardiac patients who may contract COVID-19. The new sub-study, examining Egyptian cardiac patients, bring presented at ACC Middle East 2021. #COVID19 #SARSCOV2
October 15, 2021
Poor Oral Health Impacts COVID severity, Especially in Cardiac Patients
October 15, 2021 — The correlation between poor oral health and COVID-19 (SARS-CoV-2) severity, as well as the…
Read More
The InspireMD CGuard Embolic Prevention Stent System (EPS) device for the treatment of carotid artery disease (CAD) and stroke prevention has received reimbursement in France from the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDIMTS) of the French National Authority for Health (HAS).
October 15, 2021
CGuard Embolic Prevention Carotid Stent Receives French Reimbursement Approval 
October 15, 2021 — The InspireMD CGuard Embolic Prevention Stent System (EPS) device for the treatment of carotid…
Read More
Cardiac CTA derived left atrium emptying fraction (LAEF) improves predictive performance of established clinical risk scores and may be used to assess TAVR patient risk during pre-procedure workup and post-procedural surveillance. These images show LAVmax (A and B), LAVmin (C and D), and LAEF using cardiac CTA. LAEF was calculated as (LAVmax-LAVmin)/LAVmax x 100. Given LAVmax of 109 mL and LAVmin of 80 mL, the LAEF was calculated to be 27%. Image courtesy of AJR.
October 14, 2021
Cardiac CTA Parameters Predict Post-TAVR Mortality
October 14, 2021 — Cardiac computed tomography angiography (CTA) derived left atrium emptying fraction (LAEF) improves…
Read More
Draft Recommendations Suggest Not Using Aspirin for Prevention in Many Patients. Risks vs. benefits of aspirin shows risks outweigh benefits in preventing heart attacks and strokes in many patients.
By Dave Fornell, DAIC Editor
October 13, 2021
Draft Recommendations Suggest Not Using Aspirin for Prevention in Many Patients
There has been debate in recent years over balancing the risks vs. benefits of aspirin for the prevention of heart…
Read More
FDA Grants Empagliflozin Breakthrough Therapy Status for Heart Failure With Preserved Ejection Fraction. he U.S. Food and Drug Administration (FDA) recently granted the breakthrough therapy designation for empagliflozin (Jardiance) as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF).
October 07, 2021
FDA Grants Empagliflozin Breakthrough Therapy Status for Heart Failure With Preserved Ejection Fraction
October 7, 2021 – The U.S. Food and Drug Administration (FDA) recently granted the breakthrough therapy designation for…
Read More
The Baylis VersaCross RF transseptal crossing catheter is designed to puncture the septum without a needle to allow access to the left side of the heart for mitral valve and left atrial appendage occlusion procedures. Boston Scientific to Acquire Baylis Medical for $1.75 billion.
October 06, 2021
Boston Scientific to Acquire Baylis Medical To Expand EP and Structural Heart Portfolios
October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical…
Read More
Two of the top technology headlines this past month was the FDA clearance of the Abbott Portico transcatheter aortic valve replacement (TAVR) device, and the first women to receive a Carmat artificial heart.
BY Dave Fornell, DAIC Editor
October 06, 2021
Most Popular Cardiology Technology Content in September 2021
October 6, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
October 06, 2021
First Human AFib Cases in Europe Treated Using Heliostar Balloon Ablation Catheter
October 6, 2021 – Biosense Webster announced the first cases using a radiofrequency balloon ablation catheter were…
Read More
A comparison between healthy artery (left) and inflamed artery (right) using perivascular fat attenuation index (FAI) mapping to detect spatial changes in perivascular fat composition induced by inflammation of the vascular wall caused by high-risk plaques.
October 06, 2021
CT Coronary Perivascular Fat Assessment Can Stratify Cardiac Risk Associated With High-Risk Plaques
October 6, 2021 — Data presented during the late-breaking science session at the European Society of Cardiology (ESC)…
Read More
Cardiac coronary computed tomography angiography (CCTA) exam showing different views of the myocardium and the coronary arteries. This was scanned on a Canon Aquilion Prime CT scanner. Trends in cardiac imaging. Cardiac imaging utilization report.
October 06, 2021
Trends in Cardiac Imaging Over Past Decade Shows Rapid Rise in CT
October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade…
Read More
SimpleSense is an FDA cleared remote diagnostic platform. The cloth-based nanosensor technology undergarment monitors multiple patient vitals such as heart rate, blood pressure, respiration rate, and physical activity.
October 04, 2021
FDA Clears Nanowear Platform to Implement AI-based Home Diagnostics and Monitoring Network
October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used  proprietary wearable cloth…
Read More
The Abbott Amplatzer Talisman PFO Occlusion System is designed to treat people with a patent foramen ovale (PFO). The small opening between the upper chambers of the heart can increase the risk of recurrent ischemic stroke.
October 04, 2021
FDA Clears Abbott Amplatzer Talisman PFO Occluder 
October 4, 2021 — U.S. Food and Drug Administration (FDA) has cleared the Abbott Amplatzer Talisman PFO Occlusion…
Read More
The GE Healthcare Vsan Air wireless transducer point-of-care-ultrasound system will be used in combination with UltraSight artificial intelligence technology to monitor an astronaut's heart during Rakia space mission. The research will be used to determine the possible side effects of long-duration maned flights to Mars.
October 04, 2021
AI Enabled Wireless Cardiac Point-of-Care-Ultrasound Will be Used by Astronauts in Space
October 4, 2021 – UltraSight, a digital health company developing artificial intelligence (AI) enabled cardiac imaging…
Read More
European Society of Cardiology 2021 Late-breaking hot-line Studies presented with links.
By Dave Fornell, DAIC Editor
October 04, 2021
European Society of Cardiology 2021 Late-breaking Studies 
October 4, 2021 — Here are links to all the late-breaking cardiology studies presented in Hot-Line sessions at the 2021…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now